Association between albuminuria, atherosclerotic plaques, elevated pulse wave velocity, age, risk category and prognosis in apparently healthy individuals

Journal of Hypertension

Volumn 32, Issue 5, 2014, Pages 1034-1041

  Greve, Sara V ^a   Blicher, Marie K ^a   Blyme, Adam ^b   Sehestedt, Thomas ^c   Hansen, Tine W ^d   Rassmusen, Susanne ^c   Vishram, Julie K K ^b,e   Ibsen, Hans ^f   Torp Pedersen, Christian ^b   Olsen, Michael H ^b,g  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^c GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^d STENO DIABETES CENTER   (Denmark)

^e Research Centre for Prevention and Health   (Denmark)

^f HOLBÆK HOSPITAL   (Denmark)

^g NORTH WEST UNIVERSITY   (South Africa)

Author keywords

atherosclerotic plaques; cardiovascular risk; prognosis; pulse wave velocity; subclinical organ damage; urine albumin creatinine ratio

Indexed keywords

ALBUMIN; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE; AGED; ALBUMIN BLOOD LEVEL; ALBUMINURIA; ARTICLE; ATHEROSCLEROTIC PLAQUE; BLOOD VESSEL INJURY; CAROTID ATHEROSCLEROSIS; CEREBROVASCULAR ACCIDENT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; FRAMINGHAM RISK SCORE; HEART INFARCTION; HIGH RISK POPULATION; HUMAN; INSULIN BLOOD LEVEL; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PREVALENCE; PRIORITY JOURNAL; PULSE PRESSURE; PULSE WAVE; SUBCLINICAL VASCULAR DAMAGE; TRIACYLGLYCEROL BLOOD LEVEL; ATHEROSCLEROSIS; COMPLICATION; PATHOPHYSIOLOGY; PROGNOSIS; RISK FACTOR;

AGE FACTORS; ALBUMINURIA; ATHEROSCLEROSIS; HUMANS; PROGNOSIS; PULSE WAVE ANALYSIS; RISK FACTORS;

EID: 84898487793     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0000000000000147     Document Type: Article

References (26)

1. Magnus P, Beaglehole R. The real contribution of the major risk factors to the coronary epidemics: time to end the 'only-50%' myth. Arch Intern Med 2001; 161:2657-2660.
2. Stamler J, Stamler R, Neaton JD, Wentworth D, Daviglus ML, Garside D, et al. Low risk-factor profile and long-term cardiovascular and noncardiovascular mortality and life expectancy: findings for 5 large cohorts of young adult and middle-aged men and women. JAMA 1999; 282:2012-2018.
3. Akosah KO, Schaper A, Cogbill C, Schoenfeld P. Preventing myocardial infarction in the young adult in the first place: how do the National Cholesterol Education Panel III guidelines perform? J Am Coll Cardiol 2003; 41:1475-1479.
4. Conroy RM, Pyorala K, Fitzgerald AP, Sans S, Menotti A, De Backer G, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003; 24:987-1003.
5. D'Agostino RB Sr, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 2008; 117:743-753.
6. Jensen JS, Feldt-Rasmussen B, Strandgaard S, Schroll M, Borch-Johnsen K. Arterial hypertension, microalbuminuria, and risk of ischemic heart disease. Hypertension 2000; 35:898-903.
7. Olsen MH, Hansen TW, Christensen MK, Gustafsson F, Rasmussen S, Wachtell K, et al. Cardiovascular risk prediction by N-terminal pro brain natriuretic peptide and high sensitivity C-reactive protein is affected by age and sex. J Hypertens 2008; 26:26-34.
8. Olsen MH, Hansen TW, Christensen MK, Gustafsson F, Rasmussen S, Wachtell K, et al. New risk markers may change the HeartScore risk classification significantly in one-fifth of the population. J Hum Hypertens 2009; 23:105-112.
9. Bonny A, Lacombe F, Yitemben M, Discazeaux B, Donetti J, Fahri P, et al. The 2007 ESH/ESC guidelines for the management of arterial hypertension. J Hypertens 2008; 26:825.
10. Sehestedt T, Jeppesen J, Hansen TW, Wachtell K, Ibsen H, Torp-Pedersen C, et al. Risk prediction is improved by adding markers of subclinical organ damage to SCORE. Eur Heart J 2010; 31:883-891.
11. Olsen MH, Wachtell K, Bella JN, Palmieri V, Gerdts E, Smith G, et al. Albuminuria predicts cardiovascular events independently of left ventricular mass in hypertension: a LIFE substudy. J Hum Hypertens 2004; 18:453-459.
12. Ainsworth CD, Blake CC, Tamayo A, Beletsky V, Fenster A, Spence JD. 3D ultrasound measurement of change in carotid plaque volume: a tool for rapid evaluation of new therapies. Stroke 2005; 36:1904-1909.
13. Van Bortel LM, Laurent S, Boutouyrie P, Chowienczyk P, Cruickshank JK, De Backer T, et al. Expert consensus document on the measurement of aortic stiffness in daily practice using carotid-femoral pulse wave velocity. J Hypertens 2012; 30:445-448.
14. Laurent S, Boutouyrie P, Asmar R, Gautier I, Laloux B, Guize L, et al. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 2001; 37:1236-1241.
15. Koivistoinen T, Virtanen M, Hutri-Kahonen N, Lehtimaki T, Jula A, Juonala M, et al. Arterial pulse wave velocity in relation to carotid intima-media thickness, brachial flow-mediated dilation and carotid artery distensibility: the Cardiovascular Risk in Young Finns Study and the Health 2000 Survey. Atherosclerosis 2012; 220:387-393.
16. van Popele NM, Grobbee DE, Bots ML, Asmar R, Topouchian J, Reneman RS, et al. Association between arterial stiffness and atherosclerosis: the Rotterdam Study. Stroke 2001; 32:454-460.
17. Kim BJ, Lee HA, Kim NH, Kim MW, Kim BS, Kang JH. The association of albuminuria, arterial stiffness, and blood pressure status in nondiabetic, nonhypertensive individuals. J Hypertens 2011; 29:2091-2098.
18. Divers J, Wagenknecht LE, Bowden DW, Carr JJ, Hightower RC, Register TC, et al. Ethnic differences in the relationship between pericardial adipose tissue and coronary artery calcified plaque: African- American-diabetes heart study. J Clin Endocrinol Metab 2010; 95:5382-5389.
19. Reference Values for Arterial Stiffness C. Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors: 'establishing normal and reference values'. Eur Heart J 2010; 31:2338-2350.
20. Li C, Engstrom G, Berglund G, Janzon L, Hedblad B. Incidence of ischemic stroke in relation to asymptomatic carotid artery atherosclerosis in subjects with normal blood pressure. A prospective cohort study. Cerebrovasc Dis 2008; 26:297-303.
21. Polak JF, Szklo M, Kronmal RA, Burke GL, Shea S, Zavodni AE, et al. The value of carotid artery plaque and intima-media thickness for incident cardiovascular disease: the multiethnic study of atherosclerosis. J Am Heart Assoc 2013; 2:e000087.
22. Redon J, Martinez F. Microalbuminuria as surrogate endpoint in therapeutic trials. Curr Hypertens Rep 2012; 14:345-349.
23. Folsom AR. Classical and novel biomarkers for cardiovascular risk prediction in the United States. J Epidemiol 2013; 23:158-162.
24. Verwoert GC, Elias-Smale SE, Rizopoulos D, Koller MT, Steyerberg EW, Hofman A, et al. Does aortic stiffness improve the prediction of coronary heart disease in elderly? The Rotterdam Study. J Hum Hypertens 2012; 26:28-34.
25. Blacher J, Asmar R, Djane S, London GM, Safar ME. Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients. Hypertension 1999; 33:1111-1117.
26. Karras A, Haymann JP, Bozec E, Metzger M, Jacquot C, Maruani G, et al. Large artery stiffening and remodeling are independently associated with all-cause mortality and cardiovascular events in chronic kidney disease. Hypertension 2012; 60:1451-1457.